Skip to main content

Search Results

out of 425 results
N-SSATS | National Survey of Substance Abuse Treatment Services
Collected Date: 2015-2020
Report Type: Spotlight

The White House, in collaboration with federal partners and with input from the HIV community across the United States, released the National HIV/AIDS Strategy (2022-2025) (NHAS). The fourth goal of NHAS emphasizes the need for integrated care of substance use services as a strategy to end the HIV epidemic. People...

N-SSATS | National Survey of Substance Abuse Treatment Services
Collected Date: 2015-2020
Report Type: Spotlight

The White House, in collaboration with federal partners and with input from the HIV community across the United States, released the National HIV/AIDS Strategy (2022-2025) (NHAS). The fourth goal of NHAS emphasizes the need for integrated care of substance use services as a strategy to end the HIV epidemic. People...

N-MHSS | National Mental Health Services Survey, N-SSATS | National Survey of Substance Abuse Treatment Services
Collected Date: 2015-2020
Report Type: Spotlight

Telemedicine refers to the ability for healthcare providers, working from a distance using telecommunications technology, to communicate with patients, diagnose conditions, provide treatment, and discuss healthcare issues with other providers to ensure quality healthcare services are provided1. Data from the National Survey of Substance Abuse Treatment Services (N-SSATS)...

NSDUH | National Survey on Drug Use and Health
Collected Date: 2012-2019
Report Type: Barometer

Behavioral Health Barometer: Massachusetts, Volume 6

NSDUH | National Survey on Drug Use and Health
Collected Date: 2012-2019
Report Type: Barometer

Behavioral Health Barometer: Pennsylvania, Volume 6

NSDUH | National Survey on Drug Use and Health
Collected Date: 2012-2019
Report Type: Barometer

Behavioral Health Barometer: Washington, Volume 6

NSDUH | National Survey on Drug Use and Health
Collected Date: 2014-2018
Report Type: Substate Report

Tables showing the 2014-2016 and 2016-2018 substate area estimates and the percent Bayesian confidence intervals along with an indication of statistical significance of the difference.

NSDUH | National Survey on Drug Use and Health
Collected Date: 2008-2010, 2016-2018
Report Type: Substate Report

Tables showing the 2008-2010 and 2016-2018 substate area estimates and the percent Bayesian confidence intervals along with an indication of statistical significance of the difference.

NSDUH | National Survey on Drug Use and Health
Collected Date: 2012-2017
Report Type: Barometer
NSDUH | National Survey on Drug Use and Health
Collected Date: 2012-2017
Report Type: Barometer
NSDUH | National Survey on Drug Use and Health
Collected Date: 2012-2017
Report Type: Barometer
TEDS | Treatment Episode Data Set
Collected Date: 2015
Report Type: Data Table

These tables present national-level data from the Treatment Episode Data Set (TEDS) for treatment discharges in 2015. In particular, these tables summarize demographic information and substance use treatment characteristics—including gender, age at admission, race/ethnicity, number of prior treatment episodes, treatment referral source, and length of stay in treatment—among discharges aged...

NSDUH | National Survey on Drug Use and Health
Collected Date: 2003-2016
Report Type: Data Table

These tables are special analyses that include opioid use (or heroin use and prescription pain reliever misuse) or opioid use disorders as a variable. The NSDUH survey years used, as well as by-demographic group analyses, vary.

NSDUH | National Survey on Drug Use and Health
Collected Date: 2014-2016
Report Type: Other Report or Document Type

National maps showing 2014-2016 estimates for 395 substate regions ranked from lowest to highest for each measure and divided into 7 categories.

NSDUH | National Survey on Drug Use and Health
Collected Date: 2014-2016
Report Type: Substate Report

Prevalence estimates for 15 measures of substance use and mental illness are provided along with 95% confidence intervals for persons aged 12 or older for the substance use measures, persons aged 18 or older for the mental illness measures, and persons aged 12-20 for one alcohol measure.